Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of June 2017
Filing Date: June 13, 2017
Principal Executive Offices: Else-Kröner Strasse 1, 61346 Bad Homburg, Germany
Financial Metrics
The provided filing text does not contain specific financial data. This Form 6-K serves as a cover document to submit a press release issued on June 8, 2017 (Exhibit 99.1). Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in the source text.
Material Changes
The filing text does not provide details on material changes versus prior periods. The document references an external press release for the substantive information but does not include the content of that release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are expected to be found in the referenced Exhibit 99.1 (Press Release), which is not included in the input content.
Key Facts for Investor Verification
- Verify the content of the June 8, 2017 press release (Exhibit 99.1) for actual financial results and operational updates.
- Confirm the company's status as a Foreign Private Issuer filing under Form 20-F.
- Note that the filing was signed by Rice Powell (CEO) and Michael Brosnan (CFO) on June 13, 2017.
- Check if the press release contains updated guidance or material risk factors not present in this cover filing.